Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T32HL007853, R01HL153384)
National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK128012)
Rogel Cancer Center, University of Michigan
- License Information
-
More Information
Article History
Accepted: 29 June 2023
First Online: 12 July 2023
Compliance with Ethical Standards
:
: JES reports grants and personal fees from BMS and Novartis; personal fees and non-financial support from BeiGene; personal fees from AstraZeneca, EISAI, IPSEN, and Servier, outside the submitted work. In addition, JES has patents related to the treatments of immune related adverse events pending. The remainder of the co-authors have no conflicts of interests to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
